Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

ProQR Therapeutics N.V. - Ordinary Shares (NQ:PRQR)

1.655 +0.025 (+1.53%)
Delayed Quote Updated: 10:20 AM EDT, Oct 2, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about ProQR Therapeutics N.V. - Ordinary Shares

< Previous 1 2 3 4 5 Next >
News headline image
ProQR Therapeutics Announces Transaction Completed for Théa to Acquire Sepofarsen and Ultevursen Ophthalmic Assets
From ProQR Therapeutics N.V.
Via GlobeNewswire
News headline image
US Stocks Lower; Dow Falls Over 50 Points ↗
U.S. stocks traded lower this morning, with the Dow Jones index falling over 50 points on Monday. Following the market opening Monday, the Dow traded down 0.18% to 35,328.05 while the NASDAQ fell 0.13%... 
Via Benzinga
Topics Stocks
News headline image
Bluebird Bio To Rally Around 267%? Here Are 10 Top Analyst Forecasts For Wednesday ↗
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page 
Via Benzinga
News headline image
ProQR Announces Third Quarter 2023 Operating and Financial Results
From ProQR Therapeutics N.V.
Via GlobeNewswire
News headline image
4 Analysts Have This to Say About ProQR Therapeutics ↗
 
Via Benzinga
News headline image
Analyst Ratings for ProQR Therapeutics ↗
 
Via Benzinga
News headline image
Recap: ProQR Therapeutics Q1 Earnings ↗
 
Via Benzinga
News headline image
ProQR Strengthens Leading Intellectual Property Estate for ADAR-mediated RNA Editing
From ProQR Therapeutics N.V.
Via GlobeNewswire
News headline image
ProQR Announces Participation in the Chardan 7th Annual Genetic Medicines Conference
From ProQR Therapeutics N.V.
Via GlobeNewswire
News headline image
ProQR Therapeutics Provides Update on Ophthalmic Assets
From ProQR Therapeutics N.V.
Via GlobeNewswire
News headline image
Earnings Outlook For ProQR Therapeutics ↗
 
Via Benzinga
News headline image
ProQR Announces Webcast of Presentation at the Upcoming HC Wainwright 25th Annual Global Investment Conference
From ProQR Therapeutics N.V.
Via GlobeNewswire
News headline image
ProQR Announces Second Quarter 2023 Operating and Financial Results
From ProQR Therapeutics N.V.
Via GlobeNewswire
News headline image
ProQR Therapeutics and Laboratoires Théa Announce Agreement for Théa to Acquire ProQR’s Sepofarsen and Ultevursen Ophthalmic Assets
From ProQR Therapeutics N.V.
Via GlobeNewswire
News headline image
ProQR to Present Data on its Axiomer® RNA Editing Technology at RNA Editing Summit
From ProQR Therapeutics N.V.
Via GlobeNewswire
News headline image
ProQR Announces First Quarter 2023 Operating and Financial Results
From ProQR Therapeutics N.V.
Via GlobeNewswire
News headline image
ProQR to Present its Axiomer® RNA Editing Technology at TIDES USA 2023
From ProQR Therapeutics N.V.
Via GlobeNewswire
News headline image
ProQR Announces Upcoming Investor Conferences in April and May
From ProQR Therapeutics N.V.
Via GlobeNewswire
News headline image
ProQR Announces Annual Meeting of Shareholders to be Held May 17, 2023
From ProQR Therapeutics N.V.
Via GlobeNewswire
News headline image
Why Bed Bath & Beyond Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗
Gainers SCYNEXIS, Inc. (NASDAQ: SCYX) shares climbed 68% to $2.8184 after the company announced an exclusive license agreement with GSK for Brexafemme, in which the company will receive an upfront... 
Via Benzinga
News headline image
Why Safe & Green Holdings Shares Are Trading Higher By 30%; Here Are 20 Stocks Moving Premarket ↗
Gainers Boxed, Inc. (NYSE: BOXD) gained 43.3% to $0.2303 in pre-market trading after declining 6% on Wednesday. Boxed recently said it is evaluating potentially filing for relief under the U.S.... 
Via Benzinga
News headline image
S&P 500 Up 1%; Bluebird Bio Shares Plummet ↗
U.S. stocks traded higher toward the end of trading, with the S&P 500 gaining over 1% on Wednesday. The Dow traded up 0.74% to 32,632.35 while the NASDAQ rose 1.51% to 11,893.07. The S&P 500, also... 
Via Benzinga
News headline image
Why Shares of ProQR Therapeutics Dropped on Wednesday ↗
The clinical-stage biotech released fourth-quarter and full-year earnings. 
Via The Motley Fool
News headline image
Nasdaq Rises 1%; US Pending Home Sales Increase In February ↗
U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining over 100 points on Wednesday. The Dow traded up 0.58% to 32,580.89 while the NASDAQ rose 1.09% to 11,843.85. The S&P... 
Via Benzinga
News headline image
Why Kodiak Sciences Shares Are Trading Higher By 18%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗
Gainers LogicMark, Inc. (NASDAQ: LGMK) shares jumped 76.1% to $0.2466 after the company announced financial results for the year ended 2022. The company reported FY22 revenue of $11.9 million. 
Via Benzinga
News headline image
US Stocks Open Higher, Dow Jumps Over 200 Points ↗
U.S. stocks traded higher this morning, with the Dow Jones gaining over 200 points on Wednesday. Following the market opening Wednesday, the Dow traded up 0.72% to 32,628.42 while the NASDAQ rose 1.33%... 
Via Benzinga
News headline image
ProQR Announces Initial Pipeline Targets and Highlights Axiomer® RNA Editing Platform Technology at R&D Event
From ProQR Therapeutics N.V.
Via GlobeNewswire
News headline image
ProQR Announces Successful Defense of a Key Axiomer® Patent Protecting ADAR-mediated RNA Editing
From ProQR Therapeutics N.V.
Via GlobeNewswire
News headline image
ProQR to Present at Upcoming Scientific and Industry Conferences
From ProQR Therapeutics N.V.
Via GlobeNewswire
News headline image
ProQR Therapeutics to Host Virtual R&D Event on March 29, 2023
From ProQR Therapeutics N.V.
Via GlobeNewswire
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.